Ariceum Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$52M
- Investors
-
8
Ariceum General Information
Description
Developer of targeted radiopharmaceuticals designed to visualize, diagnose, and treat aggressive and hard-to-cure cancers. The company's radiopharmaceuticals combine tumor-targeting molecules with therapeutic or diagnostic radioisotopes to selectively deliver radiation to cancer cells, with programs targeting somatostatin receptor 2 and PARP-expressing tumors, enabling medical professionals to develop better-targeted drugs to eradicate cancer more efficiently with fewer side effects.
Contact Information
Website
www.ariceum-therapeutics.comCorporate Office
- Robert-Rössle-Straße 10
- Building 79
- 13125 Berlin
- Germany
Corporate Office
- Robert-Rössle-Straße 10
- Building 79
- 13125 Berlin
- Germany
Ariceum Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 18-Apr-2023 | $52M | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Ariceum Comparisons
Industry
Financing
Details
Ariceum Competitors (52)
One of Ariceum’s 52 competitors is Ability Pharma, a Private Equity-Backed company based in Cerdanyola, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| Meditope Biosciences | Formerly VC-backed | Pasadena, CA | ||||
| Navidea Biopharmaceuticals | Corporate Backed or Acquired | Columbus, OH | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Linnaeus Therapeutics | Venture Capital-Backed | Haddonfield, NJ |
Ariceum Patents
Ariceum Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12343409-B1 | Radiopharmaceutical composition and methods | Active | 05-Jun-2024 | ||
| US-20250375541-A1 | Radiopharmaceutical composition and methods | Inactive | 05-Jun-2024 | ||
| WO-2025255396-A1 | Radiopharmaceutical composition and methods | Pending | 05-Jun-2024 | ||
| WO-2025255398-A1 | Radiopharmaceutical composition and methods | Pending | 05-Jun-2024 | ||
| AU-2023389058-A1 | Alpha emitter labelled somatostatin receptor antagonists | Pending | 06-Dec-2022 | A61K51/088 |
Ariceum Signals
Ariceum Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Andera Partners | PE/Buyout | Minority | ||
| Earlybird Venture Capital | Venture Capital | Minority | ||
| EQT Life Sciences | Venture Capital | Minority | ||
| HealthCap | Venture Capital | Minority | ||
| Ipsen | Corporation | Minority |
Ariceum Investments & Acquisitions (2)
Ariceum’s most recent deal was a Merger/Acquisition with Theragnostics for . The deal was made on 01-Jun-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Theragnostics | 01-Jun-2023 | Merger/Acquisition | Diagnostic Equipment | ||
| Ipsen (Rights to Satoreotide) | 22-Oct-2021 | Corporate Asset Purchase | Buildings and Property |
Ariceum Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Theragnostics | London, United Kingdom | 2013 |
Ariceum FAQs
-
When was Ariceum founded?
Ariceum was founded in 2021.
-
Where is Ariceum headquartered?
Ariceum is headquartered in Berlin, Germany.
-
What is the size of Ariceum?
Ariceum has 11 total employees.
-
What industry is Ariceum in?
Ariceum’s primary industry is Drug Discovery.
-
Is Ariceum a private or public company?
Ariceum is a Private company.
-
What is Ariceum’s current revenue?
The current revenue for Ariceum is .
-
How much funding has Ariceum raised over time?
Ariceum has raised $52M.
-
Who are Ariceum’s investors?
Andera Partners, Earlybird Venture Capital, EQT Life Sciences, HealthCap, and Ipsen are 5 of 8 investors who have invested in Ariceum.
-
Who are Ariceum’s competitors?
Ability Pharma, Meditope Biosciences, Navidea Biopharmaceuticals, Inovio Pharmaceuticals, and Linnaeus Therapeutics are some of the 52 competitors of Ariceum.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process